EGFR Sequecing Assay Kit

  • Print
  • Email

Life-Daan JV EGFR Sequencing Assay Kit offers broad mutation coverage of four EGFR exons, to help select non-small cell lung cancer (NSCLC) patients for treatment with EGFR inhibitors, it can test more than 40 mutations, including insertion and deletion. These mutations are tied to efficacy for non-small cell lung cancer patients with EGFR-TKI targeted therapy.

【Individuals Suitable for Testing】

Patients with NSCLC who are being considered for treatment with an EGFR antagonist.

【Testing Procedure and Analysis】

  • Polymerase chain reaction (PCR) amplification of four exons ,18, 19, 20 and 21, of the EGFR gene
  • Gene sequencing with 3500Dx and 3500Dx XL Genetic Analyzer of purified products
  • Computer analysis of sequencing data to determine mutation presence or absence


  • Low–input DNA protocol (20 ng), compatible with fresh frozen samples and formalin-fixed paraffin-embedded (FFPE) tissue samples.
  • Test results for research use only, cannot be taken as the basis of clinical diagnosis.

Treatment Strategies For Target Therapy (FDA Approved)